Quantum量子訊息有限公司
← 最新全球產業報告

DNA/Gene Microarray Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-07-14 · 259 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 5.4 Bn
2033 年預估規模
USD 9.9 Bn
年複合成長率 CAGR
9%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Healthcare & Life Sciences出版日期 2026-07-14頁數 259報告編號 CMI3825

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
DNA/Gene Microarray Market, By Type (Oligonucleotide DNA Microarrays, Complementary DNA Microarrays), By Application (Genomics, Proteomics, Agricultural Biology, Environment, Drug Research and Development, Cancer/oncology, Others (SNP Analysis, etc.)), By End User (Biopharmaceutical and Pharmaceutical Companies, Diagnostic Laboratories, Research Laboratories, Others (Academic Institutes, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

DNA Chips, Biochips or DNA microarrays consists of a microscope slide made materials such as glass, silicon chips, and nylon membrane, which is printed with thousands of minute spots. These spots contain a known DNA sequence or gene in an orderly sequence. DNA microarray uses nucleic acid hybridization principle and type of DNA microarrays include cDNA microarrays, Oligo DNA microarrays, BAC microarrays, and SNP microarrays. Applications of DNA chips include study of transcriptomes and proteomes, diagnosis of diseases, identification of microbes, and others Restraints of the Global DNA/Gene Microarray Market The high cost involved in R&D of DNA/Gene microarray technology-based products and limited financial support has posed a great challenge to growth of the global DNA/Gene microarray market. Manufacturing complexity of the biochip technology and research and development that is required to bring out innovative biochips in the market results in high costs of these products. Key features of the study • This report provides in-depth analysis of the global DNA/Gene microarray market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2026–2033), considering 2025, as the base year • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players • It profiles leading players in the global DNA/Gene microarray market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans • Key companies covered as a part of this study include Affymetrix, Inc., Illumina, Inc., Agilent Technologies Inc., Roche NimbleGen Inc., Sequenom, Inc., Biometrix Technology Inc., LC Sciences, Life Technologies Corp., Lifegen Technologies LLC, Microarrays Inc.. • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics • The global DNA/Gene microarray market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts. • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market. Market Segmentation • By Type Insights (Revenue, USD Bn, 2021 - 2033) o Oligonucleotide DNA Microarrays o Complementary DNA Microarrays • By Application Insights (Revenue, USD Bn, 2021 - 2033) o Genomics o Proteomics o Agricultural Biology o Environment o Drug Research and Development o Cancer/oncology o Others (SNP Analysis, etc.) • By End User Insights (Revenue, USD Bn, 2021 - 2033) o Biopharmaceutical and Pharmaceutical Companies o Diagnostic Laboratories o Research Laboratories o Others (Academic Institutes, etc.) • By Region Insights (Revenue, USD Bn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  North Africa  Central Africa  South Africa • Key Players in the DNA/Gene Microarray Market o Affymetrix, Inc. o Illumina, Inc. o Agilent Technologies Inc. o Roche NimbleGen Inc. o Sequenom, Inc. o Biometrix Technology Inc. o LC Sciences o Life Technologies Corp. o Lifegen Technologies LLC o Microarrays Inc. o Thermo Fisher Scientific Inc. o Bio-Rad Laboratories, Inc. o Caliper Life Sciences o Perkin Elmer, Inc. o PathogenDx, Inc. o Twist Bioscience Corporation o Arraylt Corporation o Molecular Device, LLC o Raybiotech Inc.
目錄 Table of Contents
Table of Contents 1. Research Objective and Assumption o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snippet, By Type  Market Snippet, By Application  Market Snippet, By End User  Market Snippet, By Region  Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Merger, Acquisition, and Collaborations o Regulatory Scenario o Key Developments o PEST Analysis o PORTER’S Analysis o Technological Advancements o Manufacturer Revenue 4. Global DNA/Gene Microarray Market, By Type, 2021–2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021–2033  Segment Trends o Oligonucleotide DNA Microarrays  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)  Segment Trends o Complementary DNA Microarrays  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)  Segment Trends 5. Global DNA/Gene Microarray Market, By Application, 2021–2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021–2033  Segment Trends o Genomics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)  Segment Trends o Proteomics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)  Segment Trends o Agricultural Biology  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)  Segment Trends o Environment  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)  Segment Trends o Drug Research and Development  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)  Segment Trends o Cancer/Oncology  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)  Segment Trends o Others (SNP Analysis, etc.)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)  Segment Trends 6. Global DNA/Gene Microarray Market, By End User, 2021–2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021–2033  Segment Trends o Biopharmaceutical and Pharmaceutical Companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn) o Diagnostic Laboratories  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn) o Research Laboratories  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn) o Others (Academic Institutes, etc.)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn) 7. Global DNA/Gene Microarray Market, By Region, 2021–2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021–2033  Segment Trends o North America  Introduction  Market Size and Forecast, Y-o-Y Growth and By Type, 2021–2033, (USD Bn)  Market Size and Forecast, Y-o-Y Growth and By Application, 2021–2033, (USD Bn)  Market Size and Forecast, Y-o-Y Growth and By End User, 2021–2033, (USD Bn)  Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021–2033, (USD Bn) o U.S. o Canada o Europe  Introduction  Market Size and Forecast, Y-o-Y Growth and By Type, 2021–2033, (USD Bn)  Market Size and Forecast, Y-o-Y Growth and By Application, 2021–2033, (USD Bn)  Market Size and Forecast, Y-o-Y Growth and By End User, 2021–2033, (USD Bn)  Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021–2033, (USD Bn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Market Size and Forecast, Y-o-Y Growth and By Type, 2021–2033, (USD Bn)  Market Size and Forecast, Y-o-Y Growth and By Application, 2021–2033, (USD Bn)  Market Size and Forecast, Y-o-Y Growth and By End User, 2021–2033, (USD Bn)  Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021–2033, (USD Bn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Latin America  Introduction  Market Size and Forecast, Y-o-Y Growth and By Type, 2021–2033, (USD Bn)  Market Size and Forecast, Y-o-Y Growth and By Application, 2021–2033, (USD Bn)  Market Size and Forecast, Y-o-Y Growth and By End User, 2021–2033, (USD Bn)  Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021–2033, (USD Bn) o Brazil o Mexico o Argentina o Rest of Latin America o Middle East  Market Size and Forecast, Y-o-Y Growth and By Type, 2021–2033, (USD Bn)  Market Size and Forecast, Y-o-Y Growth and By Application, 2021–2033, (USD Bn)  Market Size and Forecast, Y-o-Y Growth and By End User, 2021–2033, (USD Bn)  Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021–2033, (USD Bn) o GCC o Israel o Rest of Middle East o Africa  Market Size and Forecast, Y-o-Y Growth and By Type, 2021–2033, (USD Bn)  Market Size and Forecast, Y-o-Y Growth and By Application, 2021–2033, (USD Bn)  Market Size and Forecast, Y-o-Y Growth and By End User, 2021–2033, (USD Bn)  Market Size and Forecast, By Country, Y-o-Y Growth and By Country/ Region, 2021–2033, (USD Bn) o North Africa o Central Africa o South Africa 8. Competitive Landscape o Company Profiles  Affymetrix, Inc. o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  Illumina, Inc. o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  Agilent Technologies Inc. o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  Roche NimbleGen Inc. o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  Sequenom, Inc. o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  Biometrix Technology Inc. o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  LC Sciences o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  Life Technologies Corp. o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  Lifegen Technologies LLC o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  Microarrays Inc. o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  Thermo Fisher Scientific Inc. o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  Bio-Rad Laboratories, Inc. o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  Caliper Life Sciences o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  Perkin Elmer, Inc. o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  PathogenDx, Inc. o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  Twist Bioscience Corporation o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  Arraylt Corporation o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  Molecular Device, LLC o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies  Raybiotech Inc. o Company Overview o Product Portfolio o Key Highlights o Financial Overview o Strategies 9. Section o References o Research Methodology o About us and Sales Contact

提及公司

Affymetrix, Inc.Illumina, Inc.Agilent Technologies Inc.Roche NimbleGen Inc.Sequenom, Inc.Biometrix Technology Inc.LC SciencesLife Technologies Corp.Lifegen Technologies LLCMicroarrays Inc.Thermo Fisher Scientific Inc.Bio-Rad Laboratories, Inc.Caliper Life SciencesPerkin Elmer, Inc.PathogenDx, Inc.Twist Bioscience CorporationArraylt CorporationMolecular Device, LLCRaybiotech Inc.

同分類最新報告(醫療與生命科學)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們